- Home
- CIM vs INMD Comparison
CIM vs INMD Comparison
Compare CIM & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CIM | INMD |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 879.2M |
| IPO Year | 2007 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CIM | INMD |
|---|---|---|
| Price | $12.88 | $13.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | $15.25 | ★ $16.75 |
| AVG Volume (30 Days) | ★ 779.7K | 693.9K |
| Earning Date | 02-11-2026 | 02-10-2026 |
| Dividend Yield | ★ 11.48% | N/A |
| EPS Growth | N/A | ★ 20.42 |
| EPS | N/A | ★ 2.21 |
| Revenue | $191,573,000.00 | ★ $364,494,000.00 |
| Revenue This Year | $11.44 | N/A |
| Revenue Next Year | $21.50 | $3.33 |
| P/E Ratio | ★ N/A | $6.37 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.85 | $13.14 |
| 52 Week High | $15.37 | $19.78 |
Technical Indicators
Market Signals| Indicator | CIM | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.99 | 41.10 |
| Support Level | $12.84 | $13.73 |
| Resistance Level | $13.08 | $14.23 |
| Average True Range (ATR) | 0.28 | 0.42 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 54.46 | 9.27 |
Price Performance
Historical ComparisonAbout CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.